Richard G. Leff, M.D., QME

EDUCATION

  • Undergraduate: B.S., UCLA, 1970
  • Medical School: M.D., Albert Einstein College of Medicine: New York, 1974
  • Surgery Internship: Harbor General Hospital: Torrance, CA, 1975
  • Residency, Surgery: Harbor General Hospital: Torrance, CA, 1976
  • Residency, Urology: University of California, Davis: Sacramento, CA,1976-1979
  • Specialty Training: Renal transplantation, (1978); Pediatric urology (1979): University of California, Davis

ACADEMIC POSITIONS

  • Clinical Instructor, Urology; USC-LA County Medical Center, Los Angeles, 1988

PROFESSIONAL EXPERIENCE

  • Private practice, 1979-Present
  • Director, Positive Potency Clinic, Tarzana Regional Medical Center, 1985

LICENSURE

  • National Board of Medical Examiners
  • California State License G29796
  • DEA # AL6595966

BOARD CERTIFICATION

  • Diplomate, American Board of Urology, 1981
  •  

FELLOWSHIP

  • Fellowship, American College of Surgeons, 1983

TRAINING

  • UCLA Medical Center, extracorporeal shock wave lithotripsy, 1985

PRESENTATIONS

  • Percutaneous Nephrostomy: Presented at Western Section of American Urological Association, 1978
  • Anuria Secondary to Bilateral Uric Acid, Stones: Presented at Western Section of American Urological Association, 1978
  • Lower Extremity Complications of Lithotomy Position (with S.R. Shapiro): Presented at Western Section of American Urological Association, 1978

PUBLICATIONS

  • Leff, R.G.; Ureteroneocystostomy for Bilateral Ureteral Obstruction in Carcinoma of Prostate: Urology: Vol. XI No.6 June 1978
  • Leff, R.G.; Link, D.; Hildel, J.; Drago, R.; The Use of Percutaneous Nephrostomy in 42 Patients: Journal of Urology: Vol. 122 July 1979
  • Leff, R.G.; Lower Extremity Complications of the Lithotomy Position: Prevention and Management; Journal of Urology: Vol 12 December 1978
  • Leff, R.G.; Peterson, B.; Drago, J.R.: Cleft Glans Penis: A Case Report: Journal of Urology: Vol 120 December 1978
  • Leff, R.G.; Percutaneous Nephrostomy: Audio Digest: Vol 1 No.6 1979

CLINICAL TRIALS

  • Prostate Cancer studying drug Lupron: TAP Pharmaceutical Company, Inc., 2003
  • Overactive Bladder studying drug Fisoterodine: Schwarz Bioscience, 2003
  • Urinary Incontinence studying drug Duloxetine: Boehringlnge, 2003
  • A Phase III, Extension Study 12-Month, Open-Label, Flexibel Dose, Safety Extension, Study of Uprima Tablets (2 and 3 mg) in the Treatment of Male Erectile Dysfunction: Protocol #M01-296; TAP Pharmaceutical Company, Inc., December 2001-January 2003
  • A Phase III, Double Blind, Randomized, Parallel Study Evaluating the Safety and the Efficacy of Uprima (amormorphine FIC 1 Tablets) Sublingual (2 and 3 mg) in the Treatment of Male Erectile Dysfunction: Protocol #M01-293; TAP Pharmaceutical Company, Inc., November 2001-April 2002
  • UCLA Study: Cell Pathways, A Continued Access Program of A-ptosyn for Previously Treated PTS in Cell Pathways: May 2001-May 2002
  • Prostate Cancer studying drug Casodex: 2001
  • Overactive Bladder Study studying drug Tolterodine: 2001
  • Benign Prostatic Hyperplasia studying drug Procar by Merck: 2000-2001
  • Double Blind to Open Label Study of Zoledronate Infusion by Novartis: Study Completed 2001
  • Male Erectile Dysfunction Study using drug Uprima: 2000

 



  Our Newsletter Get in Touch   Copyright OEC 2013

 

 

 

         
 
Email
Main Office:
1 Daniel Burnham Court, Suite 365c
San Francisco, CA 94109
phone: 800.858.5447
fax: 888.240.7195